IMVT: Immunovant, Inc. Stock

by  •  • Comments Off on IMVT: Immunovant, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 2,395.04
Enterprise Value ($M) 2,020.35
Book Value ($M) 352.62
Book Value / Share 2.08
Price / Book 6.79
NCAV ($M) 344.23
NCAV / Share 2.03
Price / NCAV 6.96

Profitability (mra)
Return on Invested Capital (ROIC) -1.09
Return on Assets (ROA) -0.57
Return on Equity (ROE) -0.62

Liquidity (mrq)
Quick Ratio 6.04
Current Ratio 6.04

Balance Sheet (mrq) ($M)
Current Assets 412.54
Assets 420.93
Liabilities 68.31
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Non Redeemable Common Stock Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-21 13D/A Roivant Sciences Ltd. 56.90 0.00
03-26 13G Deep Track Capital, LP 5.59 850.00
03-07 13G/A Fmr Llc 10.10 36.22

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-28 311,490 1,222,177 25.49
2025-05-27 284,888 960,102 29.67
2025-05-23 125,879 557,263 22.59

(click for more detail)

Similar Companies
IFRX – InflaRx N.V. IGMS – IGM Biosciences, Inc.
IMUX – Immunic, Inc. INBX – Inhibrx Biosciences, Inc.
INDV – Indivior PLC


Financial data and stock pages provided by
Fintel.io